Gene · 9113
NIH grants1,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,633
Download this page as JSON| Grant | Title | LATS1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK059888 | Regulation of intestinal epithelial barrier function by intercellular junction proteins in health and disease | 1 | 2024 |
| R01DK087635 | Epigenetics of Chronic Kidney Disease | 1 | 2024 |
| R01EY013012 | Circuit formation in the visual centers | 1 | 2024 |
| R01EY017549 | Translational Research for Retinal Degeneration Therapies | 1 | 2024 |
| R01GM024485 | Molecular Basis for Transmembrane Conduction & Signaling | 1 | 2024 |
| R01GM067945 | New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin Biology | 1 | 2024 |
| R01GM099836 | Defining mechanisms of AAA+ disaggregases | 1 | 2024 |
| R01GM136976 | Structural and Functional Analyses of the Full-length Insulin Receptor (IR) and Type 1 Insulin-like Growth Factor Receptor (IGF1R) in the Liganded Active State | 1 | 2024 |
| R01HG009761 | Advancing programmable RNA-targeting tools for research and therapeutics | 1 | 2024 |
| R01HG011013 | A marker-free technology for mapping the epigenome of cell types in mammalian tissues | 1 | 2024 |
| R01HL108735 | Systems Biology Analyses for Hemodynamic Regulation of Vascular Homeostasis | 1 | 2024 |
| R01HL138720 | Removal of damaged mitochondria by alternative autophagy | 1 | 2024 |
| R01HL139584 | Targeting Matrix Stiffness in Lung Fibrosis Associated with Aging | 1 | 2024 |
| R01HL156973 | Mechano-niche in Lung Repair after Injury | 1 | 2024 |
| R01NS045630 | Laminin Receptors and Signals in Schwann Cells | 1 | 2024 |
| R01NS110627 | Transduction of Mechanical Stimuli in Myelination and Peripheral Nerve Repair | 1 | 2024 |
| R01NS113861 | Regulation and biological functions of mRNA Alternative Polyadenylation in the Brain | 1 | 2024 |
| R35CA220497 | Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance | 1 | 2024 |
| R35CA220526 | Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells | 1 | 2024 |
| RM1GM135136 | Solvation modeling for next-gen biomolecule simulations | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/grants?page=19